Drug | PMQR-negative bacterial strains | PMQR-positive bacterial strains | |||
---|---|---|---|---|---|
Total number n (%) | QnrA (n=4) |
QepA (n=5) |
AAC(6')-Ib-cr (n=3) | ||
Ampicillin | 16/42 (38.1%) |
0/12 (0%) |
0% | 0% | 0% |
Amoxicillin/clavulanate | 31/42 (73.8%) |
4/12 (33.3%) |
0% | 2/5 (40%) |
2/3 (66.7%) |
Cefotaxime | 32/42 (76.2%) |
6/12 (50%) |
1/4 (25%) |
3/5 (60%) |
2/3 (66.7%) |
Ceftriaxone | 34/42 (81%) |
5/12 (41.7%) |
1/4 (25%) |
3/5 (60%) |
1/3 (33.3%) |
Cefepime | 40/42 (95.2%) |
6/12 (50%) |
1/4 (25%) |
3/5 (60%) |
2/3 (66.7%) |
Ciprofloxacin | 38/42 (90.5%) |
4/12 (33.3%) |
1/4 (25%) |
3/5 (60%) |
0% |
Levofloxacin | 40/42 (95.2%) |
5/12 (41.7%) |
1/4 (25%) |
3/5 (60%) |
1/3 (33.3%) |
Co-trimoxazole | 38/42 (90.5%) |
8/12 (66.7%) |
1/4 (25%) |
5/5 (100%) |
2/3 (66.7%) |
Nitroxolinum | 42/42 (100%) |
7/12 (58.3%) |
0% | 5/5 (100%) |
2/3 (66.7%) |
Furazidinum | 42/42 (100%) |
5/12 (41.7%) |
0% | 5/5 (100%) |
0% |
Amikacin | 36/42 (85.7%) |
5/12 (41.7%) |
1/4 (25%) |
2/5 (40%) |
2/3 (66.7%) |
Gentamicin | 35/42 (83.3%) |
6/12 (50%) |
1/4 (25%) |
3/5 (60%) |
2/3 (66.7%) |
Nitrofurantoin | 42/42 (100%) |
6/12 (50%) |
0% | 5/5 (100%) |
1/3 (33.3%) |
Meropenem | 42/42 (100%) |
12/12 (100%) |
100% | 100% | 100% |
Fosfomycin | 39/42 (92.9%) |
6/12 (50%) |
0% | 4/5 (80%) |
2/3 (66.7%) |